Delivery Order SPE2DB24D9314-SPE2DB25FKRLW
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/mL syringes. The contract, awarded on July 23, 2025, carries an ultimate completion date of August 13, 2025, and represents a direct delivery order with no set-aside designation. This award falls under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) for the supply of Stelara 90 mg/ml syringes. The award, issued on August 20, 2025, with an ultimate completion date of September 11, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $97,499.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, issued on July 28, 2025, with an ultimate completion date of August 18, 2025, represents a tactical purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $500...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency for STELARA 90 MG/ML syringes. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, represents a specific pharmaceutical procurement under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The award...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of September 9, 2025, and carries no set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Stelara 90 mg/mL syringes. The award represents a firm fixed-price delivery order with no set-aside designation, utilizing the company's existing Indefinite Delivery Contract with DLA under the SPE2DB program. The product will be delivered to Park Ridge,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 for STELARA 90 mg/ml syringes on July 24, 2025. This delivery order, which carries an ultimate completion date of August 14, 2025, was issued without a set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain division. The award represents a single delivery order under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $48,749.85 by the Defense Logistics Agency (DLA) on July 31, 2025. The delivery order, with an ultimate completion date of August 21, 2025, covers the supply of Stelara 90 mg/ml syringes—a prescription biologic medication used primarily for treating inflammatory conditions. This award carries no set-aside designation,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order for Stelara 90 mg/mL syringes valued at $16,249.95 by the Defense Logistics Agency (DLA) on August 15, 2025. This firm fixed-price delivery order, which carries an ultimate completion date of September 8, 2025, represents a standard procurement action with no set-aside designation. The contract will be performed at the awardee's facility in Park Ridge,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award valued at approximately $195K for STELARA 90 MG/ML syringes from the Defense Logistics Agency's Medical Supply Chain on July 22, 2025. The contract represents a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's substantial...
- SPE2DB24D9314Indefinite Delivery Contract
- SPE2DB24D9314-SPE2DB25FKRLWDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Stelara 90 mg/mL syringes. This firm fixed-price delivery order, valued at $16,249.95, is scheduled for completion by August 20, 2025, with performance at the contractor's Park Ridge facility. The award carries no set-aside designation, reflecting the company's competitive standing as a certified woman-owned small business in federal procurement. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a single-award contract valued at $499,999,999 and valid through November 2026. The SPE2DB IDC enables the DLA to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities worldwide. Stelara is a biologic immunosuppressant used to treat various inflammatory conditions, and this delivery order represents a discrete fulfillment within the broader pharmaceutical supply arrangement. DMS Pharmaceutical Group's positioning as a primary supplier under this significant IDC underscores its critical role in the federal pharmaceutical supply chain, consistently delivering prescription medications, biologics, and medical consumables to military health installations. The company's established track record with the DLA and its woman-owned small business status have enabled it to maintain strong competitive positioning across multiple pharmaceutical product categories and delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 7/30/25 |